Yuji Sagara

457 total citations
18 papers, 363 citations indexed

About

Yuji Sagara is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Yuji Sagara has authored 18 papers receiving a total of 363 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Surgery, 6 papers in Pulmonary and Respiratory Medicine and 5 papers in Molecular Biology. Recurrent topics in Yuji Sagara's work include Bladder and Urothelial Cancer Treatments (6 papers), Tea Polyphenols and Effects (4 papers) and Renal cell carcinoma treatment (3 papers). Yuji Sagara is often cited by papers focused on Bladder and Urothelial Cancer Treatments (6 papers), Tea Polyphenols and Effects (4 papers) and Renal cell carcinoma treatment (3 papers). Yuji Sagara collaborates with scholars based in Japan. Yuji Sagara's co-authors include Yasuyoshi Miyata, Tomohiro Matsuo, Kojiro Ohba, Hideki Sakai, Tomayoshi Hayashi, Hiroshi Kanetake, Shinichi Watanabe, Shigeru Kanda, Yuichiro Nakamura and Kaname Ohyama and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer Research.

In The Last Decade

Yuji Sagara

18 papers receiving 359 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuji Sagara Japan 10 163 71 71 70 63 18 363
Don–Haeng Lee South Korea 9 150 0.9× 160 2.3× 29 0.4× 48 0.7× 94 1.5× 17 475
Xiaohua Tan China 12 192 1.2× 32 0.5× 51 0.7× 54 0.8× 38 0.6× 24 379
Minhua Lu China 11 193 1.2× 37 0.5× 16 0.2× 38 0.5× 30 0.5× 21 420
Tomoaki Hakariya Japan 10 98 0.6× 66 0.9× 46 0.6× 75 1.1× 42 0.7× 28 296
Yuan Zhuang China 12 153 0.9× 29 0.4× 26 0.4× 50 0.7× 66 1.0× 43 366
Konrad Zaręba Poland 11 161 1.0× 84 1.2× 47 0.7× 63 0.9× 131 2.1× 46 436
Zhe‐Ming Zhao China 11 130 0.8× 85 1.2× 22 0.3× 89 1.3× 91 1.4× 23 347
Ming–Heng Wu Taiwan 8 201 1.2× 36 0.5× 36 0.5× 108 1.5× 77 1.2× 9 435
Mitsuhiro Miyazaki Japan 13 156 1.0× 140 2.0× 38 0.5× 50 0.7× 100 1.6× 22 397

Countries citing papers authored by Yuji Sagara

Since Specialization
Citations

This map shows the geographic impact of Yuji Sagara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuji Sagara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuji Sagara more than expected).

Fields of papers citing papers by Yuji Sagara

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuji Sagara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuji Sagara. The network helps show where Yuji Sagara may publish in the future.

Co-authorship network of co-authors of Yuji Sagara

This figure shows the co-authorship network connecting the top 25 collaborators of Yuji Sagara. A scholar is included among the top collaborators of Yuji Sagara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuji Sagara. Yuji Sagara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Miyata, Yasuyoshi, Yuji Sagara, Kensuke Mitsunari, et al.. (2021). Detection of Novel Urine Markers Using Immune Complexome Analysis in Bladder Cancer Patients: A Preliminary Study. In Vivo. 35(4). 2073–2080. 5 indexed citations
2.
Nakanishi, Hiromi, Yasuyoshi Miyata, Yasushi Mochizuki, et al.. (2018). Pathological significance and prognostic roles of densities of CD57+ cells, CD68+ cells, and mast cells, and their ratios in clear cell renal cell carcinoma. Human Pathology. 79. 102–108. 18 indexed citations
3.
Miyata, Yasuyoshi, Yuichiro Nakamura, Yuji Sagara, et al.. (2018). High Consumption of Green Tea Suppresses Urinary Tract Recurrence of Urothelial Cancer via Down-regulation of Human Antigen-R Expression in Never Smokers. In Vivo. 32(4). 721–729. 7 indexed citations
4.
Miyata, Yasuyoshi, Tomohiro Matsuo, Yuichiro Nakamura, et al.. (2018). Anticancer Effects of Green Tea and the Underlying Molecular Mechanisms in Bladder Cancer. SHILAP Revista de lepidopterología. 5(3). 87–87. 45 indexed citations
5.
6.
Matsuo, Tomohiro, Yasuyoshi Miyata, Yuji Sagara, et al.. (2017). Green Tea Polyphenol Induces Changes in Cancer-Related Factors in an Animal Model of Bladder Cancer. PLoS ONE. 12(1). e0171091–e0171091. 22 indexed citations
7.
Miyata, Yasuyoshi, Tomohiro Matsuo, Yuji Sagara, et al.. (2017). A Mini-Review of Reactive Oxygen Species in Urological Cancer: Correlation with NADPH Oxidases, Angiogenesis, and Apoptosis. International Journal of Molecular Sciences. 18(10). 2214–2214. 46 indexed citations
8.
Miyata, Yasuyoshi, Shinichi Watanabe, Yuji Sagara, et al.. (2013). High Expression of HuR in Cytoplasm, but Not Nuclei, Is Associated with Malignant Aggressiveness and Prognosis in Bladder Cancer. PLoS ONE. 8(3). e59095–e59095. 54 indexed citations
9.
Miyata, Yasuyoshi, Yuji Sagara, Shinichi Watanabe, et al.. (2013). CD105 is a more appropriate marker for evaluating angiogenesis in urothelial cancer of the upper urinary tract than CD31 or CD34. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 463(5). 673–679. 40 indexed citations
10.
Miyata, Yasuyoshi, Koichiro Nomata, Kojiro Ohba, et al.. (2012). Use of low-dose combined therapy with gemcitabine and paclitaxel for advanced urothelial cancer patients with resistance to cisplatin-containing therapy: a retrospective analysis. Cancer Chemotherapy and Pharmacology. 70(3). 451–459. 8 indexed citations
11.
Miyata, Yasuyoshi, Yuji Sagara, Tomohiro Matsuo, et al.. (2011). Response of recurrent urachal cancer to gemcitabine and cisplatin therapy: a case report and literature review.. PubMed. 31(6). 2335–8. 12 indexed citations
12.
Miyata, Yasuyoshi, Shinichi Watanabe, Hajime Takahashi, et al.. (2011). Effect of maintenance chemotherapy with gemcitabine and paclitaxel on recurrent squamous cell carcinoma of the bladder: a case report.. PubMed. 31(12). 4465–8. 1 indexed citations
13.
Miyata, Yasuyoshi, Yuji Sagara, Shigeru Kanda, et al.. (2010). Expression of matrix metalloproteinase-10 in non-metastatic prostate cancer: Correlation with an imbalance in cell proliferation and apoptosis. Oncology Letters. 1(3). 417–421. 11 indexed citations
14.
Sagara, Yuji, Yasuyoshi Miyata, Koichiro Nomata, Tomayoshi Hayashi, & Hiroshi Kanetake. (2010). Green tea polyphenol suppresses tumor invasion and angiogenesis in N-butyl-(-4-hydroxybutyl) nitrosamine-induced bladder cancer. Cancer Epidemiology. 34(3). 350–354. 29 indexed citations
15.
Tanaka, Masashi, et al.. (2010). Abstract P6-11-09: Pilot Study of Irinotecan and S-1 for Advanced and Metastatic Breast Cancer. Cancer Research. 70(24_Supplement). P6–11. 1 indexed citations
16.
Miyata, Yasuyoshi, Yuji Sagara, Shigeru Kanda, Tomayoshi Hayashi, & Hiroshi Kanetake. (2009). Phosphorylated hepatocyte growth factor receptor/c-Met is associated with tumor growth and prognosis in patients with bladder cancer: correlation with matrix metalloproteinase–2 and –7 and E-cadherin. Human Pathology. 40(4). 496–504. 57 indexed citations
17.
Sagara, Yuji, Yasuyoshi Miyata, Koichiro Nomata, et al.. (2008). TFE3-renal carcinoma in an adult patient: A case with strong expression of phosphorylated hepatocyte growth factor (HGFR)/Met. Pathology - Research and Practice. 205(1). 57–61. 4 indexed citations
18.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Don–Haeng Lee Breakdown of academic impact, for papers by Xiaohua Tan Breakdown of academic impact, for papers by Minhua Lu Breakdown of academic impact, for papers by Tomoaki Hakariya Breakdown of academic impact, for papers by Yuan Zhuang Breakdown of academic impact, for papers by Konrad Zaręba Breakdown of academic impact, for papers by Zhe‐Ming Zhao Breakdown of academic impact, for papers by Ming–Heng Wu Breakdown of academic impact, for papers by Mitsuhiro Miyazaki
Rankless by CCL
2026